Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos)

…, T Gabata, Y Mori, Y Iwashita, T Hibi… - Journal of Hepato …, 2018 - Wiley Online Library
Abstract The Tokyo Guidelines 2013 (TG13) for acute cholangitis and cholecystitis were
globally disseminated and various clinical studies about the management of acute …

Tokyo Guidelines 2018: flowchart for the management of acute cholecystitis

…, HJ Asbun, I Endo, Y Iwashita, T Hibi… - Journal of Hepato …, 2018 - Wiley Online Library
We propose a new flowchart for the treatment of acute cholecystitis (AC) in the Tokyo
Guidelines 2018 (TG18). Grade III AC was not indicated for straightforward laparoscopic …

Development of the Crohn's disease digestive damage score, the Lemann score

…, G d'Haens, BG Feagan, T Hibi… - Inflammatory bowel …, 2011 - academic.oup.com
Crohn's disease (CD) is a chronic progressive destructive disease. Currently available
instruments measure disease activity at a specific point in time. An instrument to measure …

Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011

…, T Mimori, T Chiba, M Mishima, T Hibi… - Modern …, 2012 - Taylor & Francis
Abstract IgG4-related disease (IgG4-RD) is a novel clinical disease entity characterized by
elevated serum IgG4 concentration and tumefaction or tissue infiltration by IgG4+ plasma …

[BOOK][B] Monomial ideals

J Herzog, T Hibi, J Herzog, T Hibi - 2011 - Springer
Chapter 1 summarizes fundamental material on monomial ideals. In particular, we consider
the integral closure of monomial ideals, squarefree normally torsionfree ideals, squarefree …

[HTML][HTML] Unique CD14+ intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-γ axis

…, K Koganei, KS Akagawa, T Hibi - The Journal of …, 2008 - Am Soc Clin Investig
Intestinal macrophages play a central role in regulation of immune responses against
commensal bacteria. In general, intestinal macrophages lack the expression of innate …

A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease

H Ito, M Takazoe, Y Fukuda, T Hibi, K Kusugami… - Gastroenterology, 2004 - Elsevier
Background & Aims: Interleukin-6 (IL-6) regulates immune response and inflammation. We
carried out a pilot placebo-controlled study to investigate the efficacy, pharmacokinetics, and …

IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease

…, A Nakazawa, A Sugita, K Koganei, K Isobe, T Hibi - Gut, 2008 - gut.bmj.com
Background: A novel T helper (Th) cell lineage, Th17, that exclusively produces the
proinflammatory cytokine interleukin 17 (IL17) has been reported to play important roles in …

Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis

…, W Reinisch, PR Gibson, J Collins, G Järnerot, T Hibi… - Gastroenterology, 2014 - Elsevier
Background & Aims Little is known about the efficacy of golimumab, a fully human
monoclonal antibody to tumor necrosis factor (TNF)− α, for treatment of ulcerative colitis …

Lack of common NOD2 variants in Japanese patients with Crohn's disease

…, Y Koike, T Shimosegawa, T Shimoyama, T Hibi - Gastroenterology, 2002 - Elsevier
Background & Aims: Previous studies have linked Crohn's disease (CD) to the
pericentromeric region of chromosome 16 (IBD1). Three independent studies of Western …